References
- SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
- ShawihdiMThompsonEKapoorNVariation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode StatisticsGut Epub2202013
- Rami-PortaRCrowleyJJGoldstrawPThe revised TNM staging system for lung cancerAnn Thorac Cardiovasc Surg20091514919262443
- Rami-PortaRBolejackVGoldstrawPThe new tumor, node, and metastasis staging systemSemin Respir Crit Care Med2011321445121500123
- OhSHLeeBHInduction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c releaseBiochem Pharmacol200366572573112948852
- KuoPLLinCCTetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cellsLife Sci200373224325212738038
- YuVWHoWSTetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phaseOncol Rep20132962205221023525490
- ChenTJiBChenYTetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cellsJ Nat Med Epub462013
- WanJLiuTMeiLSynergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signalingBr J Cancer2013109234235023807172
- QianXYanBZhouXSynergistic antiangiogenic activity of tetrandrine combined with Endostar on the human umbilical vein endothelial cell modelCancer Biother Radiopharm201328538539023682584
- DaiCLXiongHYTangLFTetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in miceCancer Chemother Pharmacol200760574175017273824
- WeiJLiuBWangLQianXDingYYuLSynergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell linesCancer Chemother Pharmacol200760570371117256130
- SebensSSchaferHThe tumor stroma as mediator of drug resistance – a potential target to improve cancer therapy?Curr Pharm Biotechnol201213112259227221605068
- HerszényiLHritzILakatosGVargaMZTulassayZThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerInt J Mol Sci20121310132401326323202950
- RollinJRéginaSVourc’hPInfluence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancerLung Cancer200756227328017208328
- ChangKHLiaoHFChangHHInhibitory effect of tetrandrine on pulmonary metastases in CT26 colorectal adenocarcinoma-bearing BALB/c miceAm J Chin Med200432686387215673192
- GaoJLJiXHeTCTetrandrine suppresses cancer angiogenesis and metastasis in 4t1 tumor bearing miceEvid Based Complement Alternat Med2013201326506123762115
- LiSJiZZouMNieXShiYChengGPreparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrineAAPS Pharm Sci Tech201112310111018
- Sadeghi-AliabadiHMozaffariMBehdadfarBRaesizadehMZarkesh-EsfahaniHPreparation and cytotoxic evaluation of magnetite (Fe3O4) nanoparticles on breast cancer cells and its combinatory effects with doxorubicin used in hyperthermiaAvicenna J Med Biotechnol2013529610323799178
- LiRLiXXieLPreparation and evaluation of PEG-PCL nanoparticles for local tetradrine deliveryInt J Pharm2009379115816619524653
- ChenBSunQWangXReversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cellsInt J Nanomedecine200832277286
- ChengJWuWChenBAEffect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cellsInt J Medecine20094209216
- LiRXieLZhuZReversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticlesPloS One201169e2417221966359
- LiXXuHDaiXZhuZLiuBLuXEnhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancerInt J Nanomedecine2012751835190
- LiXZhenDLuXEnhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells – a possible Trojan strategy against cancerEur J Pharm Biopharm201075333434020438840
- LiXLuXXuHPaclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on “oxidation therapy”Mol Pharm20129222222922171565
- DingDLiKQinWConjugated polymer amplified far-red/near-infrared fluorescence from nanoparticles with aggregation-induced emission characteristics for targeted in vivo imagingAdv Healthcare Mater201323500507
- DingDLiKZhuZConjugated polyelectrolyte-cisplatin complex nanoparticles for simultaneous in vivo imaging and drug trackingNanoscale2011351997200221442097
- DingDZhuZLiRNanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery systemACS Nano2011542520253421428432
- DingDWangJZhuZTumor accumulation, penetration, and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticlesACS Appl Mater Interfaces2012431838184622364315
- DingDZhuZLiuQCisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumorsEur J Pharm Biopharm201179114214921272637
- IshidaTIchiharaMWangXInjection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomesJ Control Release20061121152516515818
- LeivaAQuinaFHAranedaEGargalloLRadicDNew three-arm amphiphilic and biodegradable block copolymers composed of poly(epsilon-caprolactone) and poly(N-vinyl-2-pyrrolidone). Synthesis, characterization and self-assembly in aqueous solutionJ Colloid Interface Sci2007310113614317368468
- KanedaYTsutsumiYYoshiokaYThe use of PVP as a polymeric carrier to improve the plasma half-life of drugsBiomaterials200425163259326614980420
- ZhuZLiYLiXPaclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivoJ Control Release2010142343844619896997
- LiXLiRQianXSuperior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rateEur J Pharm Biopharm200870372673418634874
- SchmidSLCarterLLATP is required for receptor-mediated endocytosis in intact cellsJ Cell Biol19901116 Pt 1230723182126013
- KimJSYoonTJYuKNCellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cellsJ Vet Sci20067432132617106221
- MpokeSSWolfeJDifferential staining of apoptotic nuclei in living cells: application to macronuclear elimination in TetrahymenaJ Histochem Cytochem19974556756839154154
- RibbleDGoldsteinNBNorrisDAShellmanYGA simple technique for quantifying apoptosis in 96-well platesBMC Biotechnol200551215885144
- RenvoizéCBiolaAPallardyMBréardJApoptosis: identification of dying cellsCell Biol Toxicol19981421111209553722
- ChenSChengACWangMSPengXDetection of apoptosis induced by new type gosling viral enteritis virus in vitro through fluo-rescein annexin V-FITC/PI double labelingWorld J Gastroenterol200814142174217818407590
- WilliamsGTSmithCAMolecular regulation of apoptosis: genetic controls on cell deathCell19937457777798104100
- ÖhlundDFranklinOLundbergELundinCSundMType IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loopBMC Cancer20131315423530721
- HardwickJMChenYBJonasEAMultipolar functions of BCL-2 proteins link energetics to apoptosisTrends Cell Biol201222631832822560661
- AdamsJMCorySThe Bcl-2 protein family: arbiters of cell survivalScience19982815381132213269735050
- HetzCAER stress signaling and the BCL-2 family of proteins: from adaptation to irreversible cellular damageAntioxid Redox Signal20079122345235517854276
- ShaoJZhengDJiangZCurcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cellsActa Biochim Biophys Sin (Shanghai)201143426727421349881
- LuXXuHSunBZhuZZhengDLiXEnhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell cultureMol Pharm20131052045205323534345
- BergersGHanahanDModes of resistance to anti-angiogenic therapyNat Rev Cancer20088859260318650835
- OskarssonTExtracellular matrix components in breast cancer progression and metastasisBreast201322Suppl 2S66S7224074795
- KoontongkaewSThe tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomasJ Cancer201341668323386906
- ValastyanSWeinbergRATumor metastasis: molecular insights and evolving paradigmsCell2011147227529222000009
- GuptaGPMassaguéJCancer metastasis: building a frameworkCell2006127467969517110329
- GroblewskaMSiewkoMMroczkoBSzmitkowskiMThe role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancerFolia Histochem Cytobiol2012501121922532131
- CookHDaviesKJHardingKGThomasDWDefective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activityJ Invest Dermatol2000115222523310951240
- GaoZLZhangCDuGYLuZJClinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinomaHepatogastroenterology200754771591159517708308